For acute detoxification needs (post-illness, after heavy alcohol consumption, environmental exposure), a single session provides immediate benefit
These documents form the audit trail that institutional review boards and quality auditors expect to see when they evaluate a study protocol
Research shows these peptides are well-tolerated, with minimal reported side effects when used responsibly and under guidance.
This idea is supported by other neurodegenerative diseases experiencing severe localized copper deficiency, such as the motor neurons of ALS patients (Hilton et al., 2024), PD patients with up to 50% reduction of copper seen in the substantia nigra (Sorenson, 2001), and notably Menkes disease which is characterized by an X-linked defect in copper transporting ATP7-A gene that leads to severe systemic copper deficiency and progressive neurodegeneration (Tmer and Mller, 2010)
Here's what we do know: Key takeaway : We need formal human trials to establish safety, optimal dosing, potential side effects, and efficacy in specific conditions